Crescent Capital Consulting’s Akamai AKAM Stock Holding History

Crescent Capital Consulting’s Portfolio AKAM Stock Details AKAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-44	Closed	-$5K	–	579
2021 Q2	$5K	Buy	+44	New	+$4.91K	﹤0.01%	405

Other funds holding AKAM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Crescent Capital Consulting's AKAM Position: Q3 2021 in Review

Crescent Capital Consulting sold out of Akamai (AKAM) in Q3 2021, closing a stake of 44 shares — an estimated $5K sold.

Crescent Capital Consulting first reported a position in AKAM in Q2 2021 and held it in 1 quarter. The position peaked at $5K in Q2 2021. 703 funds tracked by Wall St. Rank hold AKAM as of Q3 2021.

Crescent Capital Consulting reported no remaining Akamai position as of Q3 2021 after selling out during the quarter.
Crescent Capital Consulting sold 44 Akamai shares in Q3 2021, an estimated $5K.
Crescent Capital Consulting first reported a position in Akamai in Q2 2021 and held it in 1 quarter.
Crescent Capital Consulting's Akamai position peaked at $5K in Q2 2021.
703 funds tracked by Wall St. Rank held Akamai as of Q3 2021.

Based on Crescent Capital Consulting's 13F filing for Q3 2021, filed 12 Oct 2021.